C rare autosomal recessive bleeding disorder, originally described in 1948 by J. Bernard and J.P. Soulier.' It is characterized by prolonged bleeding time, thrombocytopenia, giant platelets, and markedly decreased platelet aggregation with ristocetin, but normal aggregation with other agents.*-' The primary functional abnormality in BSD results from decreased adhesiveness of these platelets to exposed s~bendothelium~~' as a result of their decreased ability to bind von Willebrand factor ( V W F ) .~.~ Studies of platelet membrane glycoproteins (GP) by Nurden and Caen in 1975" and Phillips et al in 1976" demonstrated a deficiency of GPIb in BSD patients. Later studies have also demonstrated lack of or marked deficiency of GPIX.'2,'3 GPIb, which is composed of a large (GPIba) and a small (GPIbP) subunit, and GPIX appear to form a noncovalent heterodimeric complex that serves as the vWF r e~e p t o r . '~-'~ In subsequent years, additional glycoprotein deficiencies have been identified in BSD patients, including GPV3,'2.13 and a 210,000 Kd membrane glycoprotein, which may serve as a platelet Fc recept~r.".'~ Lopez et all9 isolated a full-length cDNA for GPIba from human erythroleukemia (HEL) cells. Subsequently, two groups have sequenced the GPIba gene and shown that the entire coding region is contained within a single exon.20*21 In the present work, we have studied a BSD family with two affected siblings, and have used GPIba cDNA probes to study possible abnormalities of the GPIba gene and of gene expression in the affected patients.
METHODS

Patients.
A previously unreported BSD family with two affected siblings, the proband (patient 11-1) and her brother (patient 11-4), were studied. The proband was a 30-year-old female with a history of excessive bleeding after tonsillectomy, menorrhagia, epistaxis continuing into adulthood, and profuse bleeding associated with ear piercing. This patient's youngest brother (patient 11-4) had had frequent episodes of epistaxis, one severe enough to require hospitalization. Her two other siblings (patients 11-2 and 11-3) and her five children (patients 111-1,111-2,111-3,111-4,111-5) were all asymptomatic. The father and the mother of the proband were not available for child of the proband was AfA. while the second studied child was A/B. with neither showing any evidence of BSD. No construct of heterozygosity or homozygosity for GPl bcY alleles in this family is consistent with a model in which one or more defective GPlba alleles could produce BSD. RFLP analysis with BamHl o r Hindlll showed entirely normal patterns in the patients, indicating the absence of any gross deletion of the GPlba gene. GPlba mRNA from patient platelets was reverse transcribed and subsequently amplified by the polymerase chain reaction, demonstrating the presence of GPIba transcript. Furthermore, trace amounts of GPlb could be shown on the surface of patient platelets. Based on these results, a defect in the GPlba gene is unlikely to be the cause of BSD in this family. 0 1990 by The American Society of Hematology. study; however, both had negative histories for an abnormal bleeding tendency.
Blood from normal volunteers or from patients was collected into 1/10 volume of 3.8% sodium citrate, and platelet-rich plasma (PRP) was prepared by centrifugation at room temperature (22OC) for 50 to 90 seconds at 900g. Platelet aggregation and secretion studies were done on this citrated PRP as previously de~cribed.~~.'~ Blood from patients and from normal volunteers was collected in acid-citrate-dextrose (ACD), PRP was prepared as above, platelets were washed multiple times in phosphate-buffered saline (PBS) containing 2 mmol/L EDTA, and platelets were then labeled by the periodate-[3H] borohydride te~hnique.~' Labeled platelets were solubilized with 0.5% (vol/vol) Nonidet P40 (NP-40) in the presence of iodoacetamide (IO mmol/L), phenylmethylsulfonyl fluoride (PMSF; 1 mmol/L), and aprotinin (1%) (all obtained from Sigma Chemical Co, St Louis, MO), and subsequently processed as previously described.24 For immunoprecipitation studies, IO8 platelet equivalents of NP-40 lysate were incubated overnight at 4OC with 3.75 to 7.5 pg of the anti-GPIb MoAb AP-1 (a gift of Dr Thomas Kunicki, Milwaukee, WI) or AS-726 together with 150 p L of goat anti-mouse IgG-agarose (Sigma). Immunoprecipitate complexes were then eluted from the agarose beads in 5% sodium dodecyl sulfate (SDS). Platelet lysates or immunoprecipitates were electrophoresed nonreduced on a 5% to 15% exponential SDS-polyacrylamide gel electrophoresis (PAGE) gel, and labeled polypeptides were detected by 
RESULTS
Routine hemostatic studies.
Routine laboratory studies are shown in Table 1 (Fig 1 A) . After a 7-week exposure (Fig I B) .
GPlb could be detected in the patient. While not well visualized in the figure, a trace amount of GPlX could also be seen in the 7-week exposure of the original autoradiograph. However, the 82 Kd band corresponding to GPV remained Glycoprotein analysis. undetectable in the patient. Additionally, when 'H-labeled platelets from patient 11-1 or 11-4 were immunoprecipitated with the anti-GPlb MoAbs AP-l or AS-7, bands comigrating with normal GPlb were Seen by fluorography: however, by densitometry. the patient GPIb bands showed only I% to 5% as much intensity as the normals.
For study of the genomic structure of the GPIbu gene in the affected patients. DNA was isolated from leukocytes, digested with restriction endonucleases. and hybridized with "P-labeled full-length GPlbu cDNA probes. Genomic DNA digested with restriction enzyme BunrHl revealed a single 6.4 kb band both in normal controls and in the affected patients. When genomic DNA was digested with Hindlll. a single 12.9 kb band was seen. both in patients and in normal controls. These findings suggested that there was no gross deletion of the GPlbu gene in the amected patients.
When genomic DNA was digested with Tuq I. a constant I . I kb band was always Seen in all persons studied. However, a Tuq I polymorphism was also seen in the normal population, resulting in individuals homozygous for a 0.7 kb band. individuals heterozygous for both a 0.7 and a 4.0 kb band, and individuals homozygous for a 4.0 kb band (Fig 2) . Double digestion of genomic DNA with Bg/ I I and Tuq I, (Fig 2, lane E) , was homozygous for the 0.7 kb band (A/A). while his atfected sister, patient 11-1 (lane F), was heterozygous, showing both the 0.7 and the 4.0 kb bands (A/B). Thus, the brother and sister, both of whom have autosomal recessive BSD. did not inherit the same pair of alleles for GPlbu from their parents (Fig 4) . For personal use only. on November 15, 2017. by guest www.bloodjournal.org From that one (patient 111-2) was homozygous for the 0.7 kb band (A/A), while the other (patient 111-2) was heterozygous for the polymorphic site (A/B), but neither had any clinical or laboratory evidence of BSD.
Platelet RNA studies. To establish whether specific mRNA coding for GPIba was indeed present in the thrombocytopenic BSD patients, and to facilitate its analysis, the PCR tecnhique was used to amplify the GPIba R N A sequence. R N A samples were treated with RNase-free DNase to remove any possible contaminating genomic DNA. Two oligonucleotide primers, J9 and J10, were used to synthesize a specific GPIba cDNA from platelet mRNA. A 314 bp fragment (from bases 737 to 1051) of the R N A coding sequence for GPIba was reverse transcribed and subsequently amplified, both for patient 11-4 and for a normal control (Fig 5) . For further confirmation that the 314 bp cDNA PCR product was an amplified copy of the corresponding region in the platelet GPIba mRNA, the amplified DNA was digested with restriction endonuclease HaeIII. After ethidium bromide staining, the predicted major band corresponding to a 230 bp DNA restriction fragment was shown in both the patient and the normal control (Fig 5) . Accordingly, these studies provide evidence a t the R N A level for the expression of GPIba in the platelets of these patients with BSD.
DISCUSSION
Using DNA and R N A analysis, we have studied possible abnormalities of the GPIba gene in a family with BSD. Based upon clinical and laboratory evidence, this BSD family demonstrates a classic autosomal recessive pattern of inheritance, with the implication that a pair of defective alleles is needed in order to express disease. DNA analysis after digestion with BamHI or Hind111 showed no rearrangements or deletions of the GPIba gene in these BSD patients. Using restriction fragment length polymorphism (RFLP) analysis, we were able to show that these patients have different Tuq I polymorphic patterns, indicating that they each inherited a different pair of GPIba alleles from their parents. Patient 11-4, who is homozygous (A/A), has BSD; patient 11-1, who is heterozygous (A/B), is also affected. Furthermore, DNA analysis of two of the children of patient 11-1 revealed that one (111-1) is homozygous (A/A), while the other (111-2) is heterozygous (A/B), and neither has evidence of BSD. No construct of heterozygosity or homozygosity for GPIba alleles in this family is consistent with a model in which one or more defective G P I h alleles could produce BSD. Thus, the BSD phenotype in this family is not linked to the RFLP that marks the G P I h gene.
We have also shown the presence of mRNA encoding for GPIba in the platelets of the BSD patients. This finding is not unexpected, since by the use of sensitive detection procedures, we have also been able to demonstrate GPIb on the surface of their platelets. Detection of small amounts of platelet GPIb in other patients with BSD has also been demonstrated re~ently.~'
This report documents the usefulness of RFLP linkage analysis to identify which of several potential genes might be abnormal in a disorder characterized by the absence of a multisubunit membrane complex. Recent studies of other membrane complexes, such as platelet GPIIb-IIIa3* and the T-cell receptor/CD3 complex,33 show that normal receptor assembly may require coordinate expression of multiple subunits. Thus, in BSD a defect in the separate genes encoding any one of several membrane glycoproteins, including GPIba, GPIbB, GPIX, and, possibly, GPV, could prevent the assembly and cell surface expression of the von Willebrand factor receptor complex. 
